We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: Fujirebio has acquired ADx NeuroSciences for 40 million Euros (Photo courtesy of Pexels)

Fujirebio's Belgian Acquisition Targets Neurodegenerative Diagnostics

Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions. More...
24 Jun 2022
Image: Medix Biochemica has broadened its capabilities in diagnostic base matrices through the acquisition of BRT (Photo courtesy of Pexels)

Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology

Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market. More...
21 Jun 2022
Image: The global sepsis diagnostics market is expected to reach close to USD 1 billion by 2028 (Photo courtesy of Pexels)

Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses

The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth. More...
20 Jun 2022
Image: Mayo Clinic Platform is harnessing new technologies to change how care is provided (Photo courtesy of Mayo Clinic Platform)

BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data

Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover. More...
14 Jun 2022
Image: Sofia 2 Lyme FIA is the only FDA-approved rapid POC test on the market (Photo courtesy of Quidel)

Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing

Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond. More...
14 Jun 2022
Image: BD MAX System enables labs to fully automate and streamline their LDTs (Photo courtesy of BD)

BD and Certest Collaborate on Monkeypox Molecular Diagnostic Test

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) and CerTest Biotec (Zaragoza, Spain) have entered into a collaboration to develop a molecular diagnostic test for the Monkeypox virus. More...
09 Jun 2022
Image: The POC diagnostics devices and equipment market is estimated to be worth almost USD 29 billion in 2022 (Photo courtesy of Unsplash)

Global POC Diagnostics Devices and Equipment Market to Surpass USD 50 Billion in 2026

The global POC diagnostics devices and equipment market is expected to grow at a CAGR of 17.6% from USD 24.44 billion in 2021 to USD 28.74 billion in 2022 and is projected to grow further at a CAGR of 15.8% to reach USD 51.73 billion in 2026. More...
08 Jun 2022
Visit expo >
Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Gold Member
Immunochromatographic Assay
CRYPTO Cassette

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000 - 2026 Globetech Media.
All rights reserved.